Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04033510 · ClinicalTrials.gov registry record
Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)
A clinical trial of Atrial Fibrillation and Cognitive Impairment, sponsored by David Brunk, PA-C, MMS.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT04033510: Active study of Atrial Fibrillation and Cognitive Impairment, sponsored by David Brunk, PA-C, MMS.
NCT04033510 is a study of Atrial Fibrillation and Cognitive Impairment that is active but no longer recruiting, run by David Brunk, PA-C, MMS. The registered enrollment target is 600 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04033510, a study of Atrial Fibrillation and Cognitive Impairment, is active but no longer recruiting, sponsored by David Brunk, PA-C, MMS.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives: * First, to determine if patients with a history of AF have acute measurable changes in cognitive functioning while in an episode of AF. * Second, to collect basic insight into what specific physiologic (blood pressure, pulse oximetry, heart rate, temperature) and pharmacologic (antiarrhythmic medications, rate control medications, anticoagulants, antiplatelet medications, etc.) factors minimize the neurological impact on patients while they are in AF. It is hypothesized that when using a tablet-based cognitive testing software - Cambridge Cognition (specifically to assess executive function, learning and working memory: Rapid Visual Information Processing test, Spatial Working Memory/Spatial Span Task tests, One touch Stockings of Cambridge test, Cambridge Gambling Task, Multitasking Test/Intra-Extra Dimensional Set shift tests) - a significant difference will be noted between how the patients perform while in atrial fibrillation compared to the patients' performance while in normal sinus rhythm.
Primary Outcome
Cognitive score determined by Cambridge Cognition tablet-based cognitive testing software (CANTAB), determining if there is a significant difference between subjects in atrial fibrillation as compared to when those same subjects are in normal rhythm.
Conditions Studied
Interventions
- OTHER Standard of Care Interventions to convert patient from atrial fibrillation to normal rhythm
Study Locations (1)
Colorado
- Penrose St. Francis - Colorado Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2027-01-30 |
What the registry record for NCT04033510 still lists
NCT04033510 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (80% lower).
The record links to 6 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care Interventions to convert patient from atrial fibrillation to normal rhythm is the first listed.
NCT04033510 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04033510 about?
NCT04033510 is a clinical study titled "Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)". Objectives: * First, to determine if patients with a history of AF have acute measurable changes in cognitive functioning while in an episode of AF. * Second, to collect basic insight into what specific physiologic (blood pressure, pulse oximetry, heart rate, temperature) and pharmacologic (antiarr...
What is the current status of trial NCT04033510?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2019-08-14. Estimated completion is 2027-01-30.
What conditions does trial NCT04033510 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Cognitive Impairment, Cognitive Change, Executive Dysfunction, Cognitive Impairment, Mild.
What interventions are being tested in trial NCT04033510?
The interventions under investigation include: Standard of Care Interventions to convert patient from atrial fibrillation to normal rhythm (OTHER).
Who is sponsoring clinical trial NCT04033510?
This trial is sponsored by David Brunk, PA-C, MMS, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04033510 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04033510's enrollment target sits among peer trials
600 53rd of 202 higher than 150 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI